540359 PARMAX

Parmax Pharma Share Price

 

Stock Result Declared

 

Start SIP in PARMAX

Start SIP

Performance

  • Low
  • ₹31
  • High
  • ₹32
  • 52 Week Low
  • ₹28
  • 52 Week High
  • ₹55
  • Open Price₹32
  • Previous Close₹32
  • Volume4,777
  • 50 DMA₹33.66
  • 100 DMA₹34.13
  • 200 DMA₹35.63

Investment Returns

  • Over 1 Month -11.85%
  • Over 3 Month 0%
  • Over 6 Month -16.97%
  • Over 1 Year -22.08%

Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!

Invest Now

Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -2.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 12
  • P/B Ratio
  • -2.2
  • Average True Range
  • 3.33
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.16
  • RSI
  • 45.51
  • MFI
  • 67.55

Parmax Pharma Financials

Parmax Pharma Technicals

EMA & SMA

Current Price
₹32.00
0 (0%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹33.51
  • 50 Day
  • ₹33.66
  • 100 Day
  • ₹34.13
  • 200 Day
  • ₹35.63

Resistance and Support

31.86 Pivot Speed
  • R3 32.82
  • R2 32.45
  • R1 32.23
  • S1 31.64
  • S2 31.27
  • S3 31.05

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma has an operating revenue of Rs. 13.62 Cr. on a trailing 12-month basis. An annual revenue growth of 154% is outstanding, Pre-tax margin of -8% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 40 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Parmax Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Parmax Pharma F&O

Parmax Pharma Shareholding Pattern

30.8%
63.08%
6.12%

About Parmax Pharma

  • NSE Symbol
  • PARMAX
  • BSE Symbol
  • 540359
  • Managing Director
  • Dr. Umang Alkesh Gosalia
  • ISIN
  • INE240T01014

Similar Stocks to Parmax Pharma

Parmax Pharma FAQs

Parmax Pharma share price is ₹32 As on 16 February, 2026 | 17:37

The Market Cap of Parmax Pharma is ₹12 Cr As on 16 February, 2026 | 17:37

The P/E ratio of Parmax Pharma is -2.4 As on 16 February, 2026 | 17:37

The PB ratio of Parmax Pharma is -2.2 As on 16 February, 2026 | 17:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23